Targeted Combination Wins in KRAS-Positive Metastatic Colorectal Cancer
Standard dose of sotorasib plus panitumumab reduced risk of progression by 51% vs standard care
United States Mike Bassett Ib Codebrea Filippo Pietrantonio Miriam Koopman European Society For Medical Oncology
Source: medpagetoday.com